2017-18 HSC Section 4 Green Book

B L I NDNE S S F ROM F I L L E R

for Follow-up) Country Switzerland 9

Switzerland 11

Korea 10

Korea 12

4 days later: death Korea 14

NR Vision loss NR 13 NR NR NR 13

Outcome

NR Ocular emboli no longer visible, aphasia

LE vision loss, recovery of

ophthalmoplegia

LE vision loss, recovery of

ophthalmoplegia

recovery of ability

to walk, improved global aphasia

(Variable Time

NR LE vision loss,

Case Type of Filler Injection Site Symptoms Signs Management but multiple fat emboli in right retinal and choroidal arterioles 7 hours: global aphasia, mild right sensorimotor hemiparesis

17 Autologous fat Nose (left side) Immediate: LE vision loss, pain Ophthalmoplegia Microcatheter at proximal ophthalmic artery with mechanical thrombolysis by rotating microwire, 500,000 U of urokinase and 500 m g of tirofiban infused and wrinkle in the forehead

IV methylprednisone for 3 consecutive days

Artificial ventilation, IV dexamethasone and saline

Day 1: decreased sensation forehead, scalp, paresthesias right leg. Day 3: ophthalmoplegia, ptosis

18 Autologous fat Cheek Vision loss 5 days later: vesicular lesion on ipsilateral nose Immediate: vision loss, hemicranial pain

1 minute: mental change, aphasia, right hemiplegia. 30 minutes: drowsy, global

aphasia, right sensorimotor hemiplegia. 12 hours: deep coma, central

hyperventilation, decorticate rigidity. 2 days: necrotized left eye

Right hemiplegia, global aphasia, deviation of the head and eye to the left

4 days later: superficial skin eruption forehead

15 Autologous fat Forehead Injection day: swelling, unable to open eyelids. Day 1: LE vision loss (crow’s feet) Immediate: LE weak reaction to light,

20 Autologous fat Glabella 30 minutes: LE vision loss

pain, headaches, stuporous,

unresponsive

TABLE 1. (Continued)

14 Autologous fat NLF, lip, chin No vision change,

16 Autologous fat Periorbital area

19 Autologous fat Transverse scar

DE RMATOLOG I C S URG E RY

64